Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 22/11/19 → 30/11/21 |
Keywords
- Respiratory medicine
- Idiopathic pulmonary fibrosis
- Clinical trial
Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study with Inhaled RVT-1601 for the Treatment of Persistent Cough in Patients with Idiopathic Pulmonary Fibrosis (IPF): SCENIC Trial
- Glaspole, Ian (Primary Chief Investigator (PCI))
- Symons, Karen (Project Manager)
Project: Research